Attune Pharmaceuticals is a biotechnology company, which is focused on discovering and developing novel orally-administered small-molecule therapeutics for the treatment of rare diseases. The Company is advancing two programs, one in Hereditary Angioedema (HAE) and a second in complement-mediated diseases.